Cipla Limited (NSE:CIPLA)
India · Delayed Price · Currency is INR 1,344.00
-2.00 (-0.15%)
Oct 1, 2026, 3:15 PM IST
Cipla Market Cap
Cipla has a market cap or net worth of 1.09 trillion as of October 1, 2026. Its market cap has decreased by -10.45% in one year.
Market Cap
1.09T
Enterprise Value
994.11B
Revenue
280.68B
Ranking
n/a
PE Ratio
32.28
Stock Price
1,344.00
ChartMarket Cap Chart
Since May 30, 1996, Cipla's market cap has increased from 1.51B to 1.09T, an increase of 71,734.88%. That is a compound annual growth rate of 24.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 1.09T | -10.93% |
| Dec 31, 2025 | 1.22T | -1.14% |
| Dec 31, 2024 | 1.23T | 22.72% |
| Dec 29, 2023 | 1.01T | 15.86% |
| Dec 30, 2022 | 868.44B | 14.01% |
| Dec 31, 2021 | 761.69B | 15.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 2.50T |
| Zydus Lifesciences | 1.20T |
| Laurus Labs | 1.07T |
| Mankind Pharma | 1.05T |
| Aurobindo Pharma | 976.82B |
| Glenmark Pharmaceuticals | 688.99B |
| Alkem Laboratories | 627.72B |
| Gland Pharma | 493.20B |